Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(ADP-ribose) polymerase 5b (PARP5b), also known as tankyrase 2 (TNKS2), is an enzyme that catalyzes the transfer of ADP-ribose units to target proteins, a post-translational modification called ADP-ribosylation. TNKS2 is involved in Wnt signaling, telomere maintenance, vesicle trafficking, and DNA damage response, making it a potential therapeutic target, particularly in cancer.
Inhibition of PARP5b/TNKS2 enzymatic activity, preventing ADP-ribosylation of target proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(ADP-ribose) Polymerase 5b (PARP5b).